Rosario Isasi
#64,967
Most Influential Person Now
American lawyer
Rosario Isasi's AcademicInfluence.com Rankings
Rosario Isasilaw Degrees
Law
#2622
World Rank
#3263
Historical Rank
International Law
#1704
World Rank
#2016
Historical Rank
Download Badge
Law
Why Is Rosario Isasi Influential?
(Suggest an Edit or Addition)According to Wikipedia, Rosario Isasi is a health and human rights attorney, whose research and work focuses on the regulation of human genetic technologies. Early life and career Isasi holds a J.D. from the Pontifical Catholic University of Peru and a Master of Public Health from Boston University School of Public Health .
Rosario Isasi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Protecting the endangered human: toward an international treaty prohibiting cloning and inheritable alterations. (2002) (174)
- Human Germline Genome Editing. (2017) (156)
- CRISPR germline engineering—the community speaks (2015) (124)
- Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research Purposes (2009) (117)
- Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI). (2015) (106)
- A review of the key issues associated with the commercialization of biobanks (2014) (84)
- ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update (2021) (82)
- Editing policy to fit the genome? (2016) (82)
- Mind the gap: policy approaches to embryonic stem cell and cloning research in 50 countries. (2006) (80)
- Preimplantation genetic diagnosis: an overview of socio-ethical and legal considerations. (2006) (68)
- Debate ethics of embryo models from stem cells (2018) (68)
- iPS Cells: Mapping the Policy Issues (2009) (66)
- Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes (2020) (62)
- Including all voices in international data-sharing governance (2018) (47)
- Governing stem cell banks and registries: emerging issues. (2009) (44)
- Regulatory approaches to reproductive genetic testing. (2004) (44)
- The Stem Cell Research Environment: A Patchwork of Patchworks (2009) (43)
- Report of the International Stem Cell Banking Initiative Workshop Activity: Current Hurdles and Progress in Seed‐Stock Banking of Human Pluripotent Stem Cells (2017) (43)
- Beyond the permissibility of embryonic and stem cell research: substantive requirements and procedural safeguards. (2006) (43)
- Stem cell banking: between traceability and identifiability (2010) (40)
- Identifiability and privacy in pluripotent stem cell research. (2014) (36)
- Disclosure and management of research findings in stem cell research and banking: policy statement. (2012) (33)
- Partial Loss of USP9X Function Leads to a Male Neurodevelopmental and Behavioral Disorder Converging on Transforming Growth Factor β Signaling (2020) (33)
- Model organisms contribute to diagnosis and discovery in the undiagnosed diseases network: current state and a future vision (2021) (29)
- Informed consent in embryonic stem cell research: Are we following basic principles? (2007) (28)
- From Banking to International Governance: Fostering Innovation in Stem Cell Research (2011) (27)
- The DISCUSS Project: Induced Pluripotent Stem Cell Lines From Previously Collected Research Biospecimens and Informed Consent: Points to Consider (2013) (26)
- Legal and Ethical Approaches to Stem Cell and Cloning Research: A Comparative Analysis of Policies in Latin America, Asia, and Africa (2004) (26)
- Policy Interoperability in Stem Cell Research: Demystifying Harmonization (2009) (25)
- Use of umbilical cord blood for stem cell research. (2010) (21)
- The clinical application of gene editing: ethical and social issues. (2019) (20)
- Monetary payments for the procurement of oocytes for stem cell research: In search of ethical and political consistency. (2007) (20)
- Human gene editing: revisiting Canadian policy (2017) (20)
- The use of fresh embryos in stem cell research: ethical and policy issues. (2008) (19)
- Research ethics and stem cells (2015) (19)
- Stem cell research ethics: consensus statement on emerging issues. (2007) (18)
- Regulating Preimplantation Genetic Testing across the World: A Comparison of International Policy and Ethical Perspectives. (2020) (18)
- An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (2020) (18)
- Sustained interaction: the new normal for stem cell repositories? (2011) (17)
- The DISCUSS Project: Revised Points to Consider for the Derivation of Induced Pluripotent Stem Cell Lines From Previously Collected Research Specimens (2015) (16)
- Publishing SNP Genotypes of Human Embryonic Stem Cell Lines: Policy Statement of the International Stem Cell Forum Ethics Working Party (2011) (16)
- The human rights perspective (2002) (15)
- Uncertainty and innovation: Understanding the role of cell-based manufacturing facilities in shaping regulatory and commercialization environments (2016) (15)
- Model consent clauses for rare disease research (2019) (15)
- Oversight of human inheritable genome modification (2015) (14)
- Stem Cell Patents: European Patent Law and Ethics Report: FP6 ‘Life Sciences, Genomics and Biotechnology for Health’ (2006) (14)
- What do we do now?: Responding to claims of germline gene editing in humans (2019) (14)
- International stem cell environments: a world of difference (2009) (13)
- Policy recommendations for addressing privacy challenges associated with cell-based research and interventions (2014) (12)
- Haemophilia gene therapy: the patients’ perspective (2009) (12)
- Commonalities across computational workflows for uncovering explanatory variants in undiagnosed cases (2021) (12)
- Clinical sites of the Undiagnosed Diseases Network: Unique contributions to genomic medicine and science (2020) (12)
- Mitochondrial Replacement Therapy: The Road to the Clinic in Canada. (2017) (11)
- Data sharing in stem cell translational science: policy statement by the International Stem Cell Forum Ethics Working Party. (2015) (10)
- Addressing underrepresentation in genomics research through community engagement. (2022) (9)
- A pathway for attesting ethical provenance of cell lines: Lessons from the European human pluripotent stem cell registry (hPSCreg). (2019) (9)
- Fostering public cord blood banking and research in Canada. (2013) (9)
- Ethical, legal, and social issues (ELSI) in rare diseases: a landscape analysis from funders (2019) (9)
- Biallelic MADD variants cause a phenotypic spectrum ranging from developmental delay to a multisystem disorder. (2020) (9)
- Alliances, collaborations and consortia: the International Stem Cell Forum and its role in shaping global governance and policy. (2012) (7)
- To Clone Alone: The United Nations Human Cloning Declaration (2006) (7)
- Variants in PRKAR1B cause a neurodevelopmental disorder with autism spectrum disorder, apraxia, and insensitivity to pain (2020) (7)
- Recognizing the ethical implications of stem cell research: A call for broadening the scope (2021) (7)
- A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine (2017) (6)
- Protecting the Endangered Human: Toward an International Treaty Prohibiting Cloning and Inheritable Alterations (2002) (6)
- The Rationale for a Registry of Clinical Trials Involving Human Stem Cell Therapies (2008) (6)
- Arbitrage, bioethics, and cloning: the ABCs of gestating a United Nations Cloning Convention. (2003) (6)
- Stem cell charter. (2010) (6)
- Magnetic Resonance Imaging characteristics in case of TOR1AIP1 muscular dystrophy. (2019) (5)
- Correction: Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations (2021) (5)
- Registration of Stem Cell-Based Clinical Trials: A Scientific and Ethical Imperative (2010) (5)
- The Global Governance of Infectious Diseases: The World Health Organization and the International Health Regulations (1969) (5)
- Stem Cell Research Funding Policies and Dynamic Innovation: A Survey of Open Access and Commercialization Requirements (2014) (5)
- Enabling advanced cell therapies (EnACT): invitation to an online forum on resolving barriers to clinical translation. (2012) (5)
- The human embryo: ethical and legal aspects. (2009) (5)
- CellCAN: a unique enabler of regenerative medicine and cell therapy in Canada. (2014) (4)
- One is the loneliest number: genotypic matchmaking using the electronic health record (2021) (4)
- Catalyzing umbilical cord blood research in Canada: a survey of current needs and practices of principal investigators. (2009) (4)
- Ethics Issues in Stem Cell Research (2006) (4)
- Assessing opportunities and challenges for establishing a national program to distribute cord blood for research (2018) (3)
- Erratum: De Novo Variants in WDR37 Are Associated with Epilepsy, Colobomas, Dysmorphism, Developmental Delay, Intellectual Disability, and Cerebellar Hypoplasia (The American Journal of Human Genetics (2019) 105(2) (413–424), (S0002929719302393), (10.1016/j.ajhg.2019.06.014)) (2019) (3)
- Dissecting the role of Amerindian genetic ancestry and ApoE ε4 allele on Alzheimer disease in an admixed Peruvian population (2020) (3)
- Genetics and stem cell research : models of international policy-making (2010) (2)
- Author Correction: Biallelic mutations in SORD cause a common and potentially treatable hereditary neuropathy with implications for diabetes (2020) (2)
- Human Gene Editing (2021) (2)
- Country Reports (2019) (2)
- Regenerative medicine: socio-ethical challenges and regulatory approaches (2014) (2)
- Bioethics: Justice in genomics (2017) (2)
- Streamlining ethics review for international health research. (2022) (1)
- Correction to: An autosomal dominant neurological disorder caused by de novo variants in FAR1 resulting in uncontrolled synthesis of ether lipids (2021) (1)
- Human Genome Editing: Reflections on Policy Convergence and Global Governance (2018) (1)
- Roles and responsibilities in stem cell research: a focus group study with stem cell researchers and patients. (2022) (1)
- Including all voices in international data-sharing governance (2018) (1)
- Stem Cell Research and Banking: Towards Policy on Disclosing Research Results and Incidental Findings (2014) (1)
- STEM CELL BANKS investing in the promise of cancer stem cell science (2012) (1)
- Phenotypic expansion of CACNA1C-associated disorders to include isolated neurological manifestations (2021) (1)
- Policy recommendations for addressing privacy challenges associated with cell-based research and interventions (2014) (1)
- Investigation of hypertension and type 2 diabetes as risk factors for dementia in the All of Us cohort (2022) (1)
- Developing Educational Resources to Advance Umbilical Cord Blood Banking and Research: A Canadian Perspective. (2015) (1)
- Regulating human genetic research in Latin America: a race to the top or a race together? (2016) (0)
- Discussion (day 1 session 3): Moral philosophy of human reproductive cloning. (2005) (0)
- Helping the science speak for itself: lessons learned developing video summaries for a precision medicine and health disparities collaborative. (2022) (0)
- Latin American Immigrant Juveniles in the U.S.: an Army of Delinquents or the Victims of a Racist System? (2018) (0)
- Ethical, legal, and social issues (ELSI) in rare diseases: a landscape analysis from funders (2019) (0)
- Exploring the role of Amerindian genetic ancestry and ApoEε4 gene on Alzheimer disease in the Peruvian population (2020) (0)
- Age-Related Effects of Genetic Variation on Lipid Levels: The Columbia (2013) (0)
- Models of International Policy-making (2010) (0)
- The Regulation of Human Germline Genome Modification in the People’s Republic of China (2020) (0)
- Governing Stem Cells: Regenerative Medicine in Europe - The Vision and Recommendations From the EUCelLEX Project (2018) (0)
- Oocyte donation for stem cell research. (2007) (0)
- iPS Cells: Don’t Forget about the Soft Impacts (2021) (0)
- Why the United Nations failed to agreed on human cloning (2018) (0)
- VarSight: prioritizing clinically reported variants with binary classification algorithms (2019) (0)
- Responsible innovation in stem cell research: using responsibility as a strategy. (2023) (0)
- Model consent clauses for rare disease research (2019) (0)
- Model consent clauses for rare disease research (2019) (0)
- Modeling policy development: examining national governance of stem cell-based embryo models. (2023) (0)
- Stem Cell Research Funding Policies and Dynamic Innovation: A Survey of Open Access and Commercialization Requirements (2014) (0)
- Community genetics: Genetics boosts US–Cuban links (2016) (0)
- THE LATINO EPIDEMIOLOGICAL PARADOX IN CARDIOVASCULAR DISEASE IN THE ALL OF US RESEARCH PROGRAM (2021) (0)
- The role of canadian cell manufacturing facilities in shaping the regulatory and commercialization environments (2015) (0)
- [HumGen in Spain: a legislative and political tool in human genomics and public health]. (2011) (0)
- Regulatory approaches to reproductive testing (2004) (0)
- ASHG POSITION STATEMENT Human Germline Genome Editing (2017) (0)
- Awareness and utilization of genetic testing among Hispanic and Latino adults living in the US: The Hispanic Community Health Study/Study of Latinos (2022) (0)
- A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine (2017) (0)
- Human gene editing: revisiting Canadian policy (2017) (0)
- Clinical profile of an Alzheimer´s disease cohort in the Peruvian population (2021) (0)
- Exploring effect of known Alzheimer disease genetic loci in the Peruvian population (2022) (0)
- Debate ethics of embryo models from stem cells (2018) (0)
- The Potential Effects of the United States Abortion Ruling on Global Embryo/Foetal and Stem Cell Research (2022) (0)
- The Peruvian Alzheimer Disease Initiative (PeADI): An international effort model to increase diversity in AD research (2022) (0)
- What do we do now?: Responding to claims of germline gene editing in humans (2019) (0)
- Revisiting the Latino Epidemiologic Paradox: an Analysis of Data from the All of Us Research Program (2022) (0)
- Bi-allelic variants in INTS11 are associated with a complex neurological disorder. (2023) (0)
- Participation in a national diagnostic research study: assessing the patient experience (2023) (0)
- Bi-allelic ATG4D variants are associated with a neurodevelopmental disorder characterized by speech and motor impairment (2023) (0)
- Admixed ancestral composition with Amerindian predominance at the Peruvian Alzheimer Disease Initiative (PeADI) (2022) (0)
This paper list is powered by the following services:
Other Resources About Rosario Isasi
What Schools Are Affiliated With Rosario Isasi?
Rosario Isasi is affiliated with the following schools:
